Ep. 60 - Public opinions on Wegovy and other weight loss drugs
MP3•Episoder hjem
Manage episode 375124383 series 3502474
Innhold levert av Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Fulcrum Strategies, LLC, Fulcrum Strategies, and LLC eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Matthew Handley and Ron Howrigon discuss the ongoing relevance of COVID, the cost of weight loss drugs in the US, and public opinion on prescription weight loss drugs. Key highlights
…
continue reading
- COVID still matters, especially for those at risk
- The cost of weight loss drugs in the US compared to other countries
- The need for a free market economy in healthcare
- Public opinion on prescription weight loss drugs
- The potential impact of covering weight loss drugs under insurance
- COVID can still be severe for at-risk populations
- Vaccines can help prevent severe symptoms
- The US pays more for weight loss drugs compared to other countries
- The prevalence of obesity is high in the US
- The cost of covering weight loss drugs for all Americans would be significant
- Stay informed about the ongoing impact of COVID
- Consider the cost of weight loss drugs and explore alternative options
- Share your opinion on prescription weight loss drugs
- Advocate for healthcare policies that promote a free market economy
117 episoder